FDA Inspection 1281346 — Asoke Roy, M.D.

Asoke Roy, M.D. — FEI 3036584144

The FDA completed an inspection of Asoke Roy, M.D. on Sep 4, 2025 in Basingstoke. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Sep 4, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Basingstoke (United Kingdom)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.